Auto - Parts
Compare Stocks
5 / 10Stock Comparison
THRM vs NXRT vs IRT vs MPAA vs DORM
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
REIT - Residential
Auto - Parts
Auto - Parts
THRM vs NXRT vs IRT vs MPAA vs DORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Parts | REIT - Residential | REIT - Residential | Auto - Parts | Auto - Parts |
| Market Cap | $944M | $756M | $3.86B | $220M | $3.72B |
| Revenue (TTM) | $1.53B | $252M | $662M | $771M | $2.15B |
| Net Income (TTM) | $23M | $-32M | $48M | $2M | $190M |
| Gross Margin | 23.6% | 91.1% | 20.2% | 19.2% | 40.7% |
| Operating Margin | 4.7% | 11.5% | 17.5% | 6.1% | 15.6% |
| Forward P/E | 11.6x | — | 99.9x | 15.3x | 15.0x |
| Total Debt | $295M | $1.56B | $2.28B | $201M | $633M |
| Cash & Equiv. | $161M | $14M | $48M | $9M | $49M |
THRM vs NXRT vs IRT vs MPAA vs DORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gentherm Incorporat… (THRM) | 100 | 75.7 | -24.3% |
| NexPoint Residentia… (NXRT) | 100 | 93.2 | -6.8% |
| Independence Realty… (IRT) | 100 | 165.5 | +65.5% |
| Motorcar Parts of A… (MPAA) | 100 | 72.5 | -27.5% |
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THRM vs NXRT vs IRT vs MPAA vs DORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THRM is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (11.6x vs 15.0x)
NXRT ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- 211.1% 10Y total return vs IRT's 191.8%
- Beta 0.62, yield 7.1%, current ratio 0.48x
- 7.1% yield, 12-year raise streak, vs IRT's 4.0%, (3 stocks pay no dividend)
IRT is the clearest fit if your priority is stability.
- Beta 0.48 vs THRM's 1.43
MPAA is the clearest fit if your priority is momentum.
- +24.3% vs NXRT's -15.2%
DORM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
- 6.0% revenue growth vs NXRT's -3.2%
- 8.8% margin vs NXRT's -12.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs NXRT's -3.2% | |
| Value | Lower P/E (11.6x vs 15.0x) | |
| Quality / Margins | 8.8% margin vs NXRT's -12.7% | |
| Stability / Safety | Beta 0.48 vs THRM's 1.43 | |
| Dividends | 7.1% yield, 12-year raise streak, vs IRT's 4.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +24.3% vs NXRT's -15.2% | |
| Efficiency (ROA) | 7.6% ROA vs NXRT's -1.7%, ROIC 13.9% vs 1.1% |
THRM vs NXRT vs IRT vs MPAA vs DORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
THRM vs NXRT vs IRT vs MPAA vs DORM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NXRT leads in 2 of 6 categories
MPAA leads 2 • DORM leads 1 • IRT leads 1 • THRM leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
NXRT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DORM is the larger business by revenue, generating $2.2B annually — 8.6x NXRT's $252M. DORM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, THRM holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $252M | $662M | $771M | $2.2B |
| EBITDAEarnings before interest/tax | $127M | $125M | $365M | $49M | $377M |
| Net IncomeAfter-tax profit | $23M | -$32M | $48M | $2M | $190M |
| Free Cash FlowCash after capex | $79M | $79M | $139M | $30M | $71M |
| Gross MarginGross profit ÷ Revenue | +23.6% | +91.1% | +20.2% | +19.2% | +40.7% |
| Operating MarginEBIT ÷ Revenue | +4.7% | +11.5% | +17.5% | +6.1% | +15.6% |
| Net MarginNet income ÷ Revenue | +1.5% | -12.7% | +7.3% | +0.3% | +8.8% |
| FCF MarginFCF ÷ Revenue | +5.1% | +31.2% | +21.1% | +3.9% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.3% | +0.5% | +2.5% | -9.9% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | 0.0% | -101.4% | -18.2% | -23.5% |
Valuation Metrics
MPAA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, DORM trades at a 73% valuation discount to IRT's 68.2x P/E. On an enterprise value basis, MPAA's 8.2x EV/EBITDA is more attractive than NXRT's 18.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $944M | $756M | $3.9B | $220M | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $2.3B | $6.1B | $412M | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 51.35x | -23.65x | 68.21x | -11.59x | 18.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.57x | — | 99.88x | 15.29x | 15.05x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.25x |
| EV / EBITDAEnterprise value multiple | 8.21x | 18.60x | 16.71x | 8.19x | 10.41x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 3.01x | 5.87x | 0.29x | 1.75x |
| Price / BookPrice ÷ Book value/share | 1.32x | 2.52x | 1.07x | 0.88x | 2.59x |
| Price / FCFMarket cap ÷ FCF | 15.45x | 9.05x | 26.33x | 5.39x | 49.18x |
Profitability & Efficiency
DORM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DORM delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-10 for NXRT. THRM carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), MPAA scores 7/9 vs NXRT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.2% | -10.1% | +1.3% | +0.8% | +13.1% |
| ROA (TTM)Return on assets | +1.6% | -1.7% | +0.8% | +0.2% | +7.6% |
| ROICReturn on invested capital | +7.3% | +1.1% | +1.6% | +6.2% | +13.9% |
| ROCEReturn on capital employed | +8.2% | +1.5% | +2.4% | +6.6% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.41x | 5.18x | 0.64x | 0.78x | 0.43x |
| Net DebtTotal debt minus cash | $134M | $1.5B | $2.2B | $192M | $584M |
| Cash & Equiv.Liquid assets | $161M | $14M | $48M | $9M | $49M |
| Total DebtShort + long-term debt | $295M | $1.6B | $2.3B | $201M | $633M |
| Interest CoverageEBIT ÷ Interest expense | 5.83x | 0.47x | 1.73x | 0.94x | 8.24x |
Total Returns (Dividends Reinvested)
MPAA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DORM five years ago would be worth $11,922 today (with dividends reinvested), compared to $4,200 for THRM. Over the past 12 months, MPAA leads with a +24.3% total return vs NXRT's -15.2%. The 3-year compound annual growth rate (CAGR) favors MPAA at 34.5% vs THRM's -19.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.3% | +2.6% | -6.0% | -7.2% | +0.3% |
| 1-Year ReturnPast 12 months | +19.1% | -15.2% | -11.9% | +24.3% | +0.5% |
| 3-Year ReturnCumulative with dividends | -48.0% | -15.5% | +7.4% | +143.5% | +41.6% |
| 5-Year ReturnCumulative with dividends | -58.0% | -23.0% | +17.8% | -51.7% | +19.2% |
| 10-Year ReturnCumulative with dividends | -14.9% | +211.1% | +191.8% | -62.7% | +129.7% |
| CAGR (3Y)Annualised 3-year return | -19.6% | -5.5% | +2.4% | +34.5% | +12.3% |
Risk & Volatility
IRT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IRT is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than THRM's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IRT currently trades 83.5% from its 52-week high vs MPAA's 63.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 0.62x | 0.48x | 0.99x | 0.85x |
| 52-Week HighHighest price in past year | $39.48 | $38.30 | $19.61 | $18.12 | $166.89 |
| 52-Week LowLowest price in past year | $25.47 | $23.79 | $14.60 | $9.09 | $98.44 |
| % of 52W HighCurrent price vs 52-week peak | +78.0% | +77.8% | +83.5% | +63.3% | +74.6% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 71.0 | 62.4 | 58.0 | 71.2 |
| Avg Volume (50D)Average daily shares traded | 239K | 216K | 2.2M | 87K | 273K |
Analyst Outlook
NXRT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: THRM as "Buy", NXRT as "Hold", IRT as "Buy", MPAA as "Buy", DORM as "Buy". Consensus price targets imply 74.4% upside for MPAA (target: $20) vs -9.4% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.07% vs IRT's 4.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $36.67 | $27.00 | $20.08 | $20.00 | $140.00 |
| # AnalystsCovering analysts | 15 | 10 | 27 | 7 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% | +4.0% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 12 | 4 | — | 2 |
| Dividend / ShareAnnual DPS | — | $2.11 | $0.66 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +1.0% | +0.8% | +2.2% | +1.1% |
NXRT leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). MPAA leads in 2 (Valuation Metrics, Total Returns).
THRM vs NXRT vs IRT vs MPAA vs DORM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is THRM or NXRT or IRT or MPAA or DORM a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). Dorman Products, Inc. (DORM) offers the better valuation at 18. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Gentherm Incorporated (THRM) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THRM or NXRT or IRT or MPAA or DORM?
On trailing P/E, Dorman Products, Inc.
(DORM) is the cheapest at 18. 8x versus Independence Realty Trust, Inc. at 68. 2x. On forward P/E, Gentherm Incorporated is actually cheaper at 11. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — THRM or NXRT or IRT or MPAA or DORM?
Over the past 5 years, Dorman Products, Inc.
(DORM) delivered a total return of +19. 2%, compared to -58. 0% for Gentherm Incorporated (THRM). Over 10 years, the gap is even starker: NXRT returned +211. 1% versus MPAA's -62. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THRM or NXRT or IRT or MPAA or DORM?
By beta (market sensitivity over 5 years), Independence Realty Trust, Inc.
(IRT) is the lower-risk stock at 0. 48β versus Gentherm Incorporated's 1. 43β — meaning THRM is approximately 196% more volatile than IRT relative to the S&P 500. On balance sheet safety, Gentherm Incorporated (THRM) carries a lower debt/equity ratio of 41% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — THRM or NXRT or IRT or MPAA or DORM?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Motorcar Parts of America, Inc. grew EPS 60. 6% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THRM or NXRT or IRT or MPAA or DORM?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRT leads at 18. 4% versus 5. 2% for THRM. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THRM or NXRT or IRT or MPAA or DORM more undervalued right now?
On forward earnings alone, Gentherm Incorporated (THRM) trades at 11.
6x forward P/E versus 99. 9x for Independence Realty Trust, Inc. — 88. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MPAA: 74. 4% to $20. 00.
08Which pays a better dividend — THRM or NXRT or IRT or MPAA or DORM?
In this comparison, NXRT (7.
1% yield), IRT (4. 0% yield) pay a dividend. THRM, MPAA, DORM do not pay a meaningful dividend and should not be held primarily for income.
09Is THRM or NXRT or IRT or MPAA or DORM better for a retirement portfolio?
For long-horizon retirement investors, Independence Realty Trust, Inc.
(IRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 4. 0% yield, +191. 8% 10Y return). Both have compounded well over 10 years (IRT: +191. 8%, THRM: -14. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THRM and NXRT and IRT and MPAA and DORM?
These companies operate in different sectors (THRM (Consumer Cyclical) and NXRT (Real Estate) and IRT (Real Estate) and MPAA (Consumer Cyclical) and DORM (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: THRM is a small-cap quality compounder stock; NXRT is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock; MPAA is a small-cap quality compounder stock; DORM is a small-cap quality compounder stock. NXRT, IRT pay a dividend while THRM, MPAA, DORM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.